Phreesia (NYSE:PHR) General Counsel Sells $48,386.50 in Stock

Key Points

• Allison Hoffman, Phreesia's General Counsel, sold 2,059 shares at an average price of $23.50, reducing her ownership by 1.48% while still holding 136,978 shares valued at approximately $3.22 million.
• Phreesia's stock performance shows a trading increase, with shares recently valued at $24.28, and the company's revenue grew by 14.9% year-over-year to $117.26 million.
• Analysts have largely rated Phreesia's stock positively, with a consensus target price of $34.08, indicating a general optimism about its future performance.

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 2,059 shares of the firm's stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $23.50, for a total value of $48,386.50. Following the completion of the transaction, the general counsel owned 136,978 shares of the company's stock, valued at $3,218,983. The trade was a 1.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Phreesia Stock Down 1.3%

Shares of NYSE PHR traded down $0.32 during mid-day trading on Friday, hitting $23.87. The company had a trading volume of 1,446,722 shares, compared to its average volume of 1,195,076. The company has a market capitalization of $1.43 billion, a PE ratio of -56.83 and a beta of 0.72. The firm has a 50-day simple moving average of $27.57 and a two-hundred day simple moving average of $26.38. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a one year low of $17.07 and a one year high of $32.76.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The company had revenue of $117.26 million during the quarter, compared to analysts' expectations of $116.39 million. During the same quarter last year, the company earned ($0.03) EPS. Phreesia's revenue for the quarter was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. On average, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Analyst Ratings Changes

PHR has been the subject of several recent analyst reports. Mizuho initiated coverage on shares of Phreesia in a research note on Wednesday, August 27th. They issued an "outperform" rating and a $36.00 target price for the company. Canaccord Genuity Group raised their target price on shares of Phreesia from $34.00 to $38.00 and gave the company a "buy" rating in a research note on Friday, September 5th. JMP Securities raised their target price on shares of Phreesia from $30.00 to $34.00 and gave the company a "market outperform" rating in a research note on Monday, September 8th. KeyCorp raised their price objective on shares of Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. One research analyst has rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company. According to data from MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and a consensus target price of $34.08.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in PHR. KBC Group NV bought a new stake in shares of Phreesia during the first quarter worth approximately $74,000. Farther Finance Advisors LLC increased its stake in Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock worth $86,000 after acquiring an additional 3,000 shares during the period. CWM LLC raised its holdings in Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after acquiring an additional 3,671 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Phreesia by 53.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company's stock valued at $137,000 after acquiring an additional 1,825 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Phreesia by 10,605.7% in the 1st quarter. GAMMA Investing LLC now owns 5,674 shares of the company's stock valued at $145,000 after acquiring an additional 5,621 shares in the last quarter. Institutional investors own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.